Lars Egevad
Impact in
- Pulmonary and Respiratory Medicine top 0.05%
- Prostate Cancer Diagnosis and Treatment
- Prostate Cancer Treatment and Research
- Renal cell carcinoma treatment
- Cancer Research top 0.5%
- Cancer, Lipids, and Metabolism
Papers in
-
- Prostate Cancer Diagnosis and Treatment 202
- Prostate Cancer Treatment and Research 128
- Renal cell carcinoma treatment 31
- Rheumatology 65
- Urologic and reproductive health conditions 61
- Co-authors
- Brett Delahunt (106 shared papers)John R. Srigley (57 shared papers)Jonathan I. Epstein (27 shared papers)Peter A. Humphrey (20 shared papers)Mahul B. Amin (16 shared papers)Rodolfo Montironi (47 shared papers)Pär E. Stattin (40 shared papers)Hemamali Samaratunga (85 shared papers)
- Journals
- Pathology (33 papers)Histopathology (30 papers)The American Journal of Surgical Pathology (28 papers)Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin (21 papers)European Urology (20 papers)
- Partner nations
- SwedenUnited StatesNew Zealand
In The Last Decade
Lars Egevad
399 papers receiving 23.4k citations
Lars Egevad's Hit Papers
Peers
Comparison fields: 5 of 173
- Pulmonary and Respiratory Medicine 13.6k
- Cancer Research 3.2k
- Rheumatology 2.0k
- Oncology 2.9k
- Health Informatics 152
Countries citing papers authored by Lars Egevad
This map shows the geographic impact of Lars Egevad's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lars Egevad with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lars Egevad more than expected).
Fields of papers citing papers by Lars Egevad
This network shows the impact of papers produced by Lars Egevad. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lars Egevad. The network helps show where Lars Egevad may publish in the future.
Co-authors
The 25 scholars most cited alongside Lars Egevad, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 406 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma Hit paper breakdown → | 2015 | 2499 |
| 2 | A Contemporary Prostate Cancer Grading System: A Validated Alternative to the Gleason Score Hit paper breakdown → | 2015 | 1072 |
| 3 | Gene expression profiling identifies clinically relevant subtypes of prostate cancer Hit paper breakdown → | 2004 | 1062 |
| 4 | The International Society of Urological Pathology (ISUP) Vancouver Classification of Renal Neoplasia Hit paper breakdown → | 2013 | 821 |
| 5 | The International Society of Urological Pathology (ISUP) Grading System for Renal Cell Carcinoma and Other Prognostic Parameters Hit paper breakdown → | 2013 | 644 |
| 6 | Artificial intelligence for diagnosis and grading of prostate cancer in biopsies: a population-based, diagnostic study Hit paper breakdown → | 2020 | 463 |
| 7 | 1997 | 373 | |
| 8 | 2006 | 355 | |
| 9 | 2010 | 352 | |
| 10 | Prostate cancer screening in men aged 50–69 years (STHLM3): a prospective population-based diagnostic study Hit paper breakdown → | 2015 | 333 |
| 11 | 2000 | 292 | |
| 12 | 2014 | 264 | |
| 13 | 2015 | 248 | |
| 14 | Prostate Cancer Screening with PSA and MRI Followed by Targeted Biopsy Only Hit paper breakdown → | 2022 | 240 |
| 15 | 2010 | 217 | |
| 16 | 2009 | 210 | |
| 17 | 2010 | 201 | |
| 18 | 2009 | 196 | |
| 19 | 2005 | 190 | |
| 20 | 2010 | 181 |
About Lars Egevad
Lars Egevad is a scholar working on Pulmonary and Respiratory Medicine, Rheumatology, Surgery, Cancer Research and Oncology, having authored 406 papers that have together received 23.9k indexed citations. Recurring topics across this work include Prostate Cancer Diagnosis and Treatment (202 papers), Prostate Cancer Treatment and Research (128 papers), Urologic and reproductive health conditions (61 papers), Bladder and Urothelial Cancer Treatments (37 papers), Renal cell carcinoma treatment (31 papers), Genital Health and Disease (22 papers), Renal and related cancers (22 papers) and AI in cancer detection (19 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (13.6k citations), Cancer Research (3.2k citations), Rheumatology (2.0k citations), Oncology (2.9k citations) and Health Informatics (152 citations). Lars Egevad has collaborated with scholars based in Sweden, United States and New Zealand. Frequent co-authors include Brett Delahunt, John R. Srigley, Jonathan I. Epstein, Peter A. Humphrey, Mahul B. Amin, Rodolfo Montironi, Pär E. Stattin, Hemamali Samaratunga, Anders R. J. Bergh and David J. Grignon. Their work appears in journals such as Pathology, Histopathology, The American Journal of Surgical Pathology, Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin and European Urology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.